Get in touch (813) 875-6600

History

1990

The beginning

1995

Incorporated

1996

Operations at UF

1998

SBIR Grant from NCI
SBIR Grant from NHLBI

2001

Completes First Round of Equity Finance

2003

Established Tampa Bay office

2005

ImmuneFx Rescues Neuroblastoma Mice
First MG-1 Patent Issued
PACS 1st Prototype

2006

First ImmuneFx Patent
First PACS Patent
ImmuneFx Canine Lymphoma Study Begins
First MATCH Patent

2007

Joint Effort is Established with St. Joseph’s Hospital

2009

PACT Grant from NHLBI
QTDP Grant from the Department of HHS and the IRS
Finalist in World Technology Summit

2010

Incorporated VOS

2012

Featured in Florida Trend
Consolidates headquarters in Tampa
Featured on ABC News
Pat Lawman Tampa Bay Technology Business Woman of the Year

2013

Pre-IND Meeting with FDA
Precedent-setting Meeting with RAC
Path for Human Testing of ImmuneFx
USDA Authorized Marketing of Personalized ImmuneFx

2014

2nd Generation PACS Prototype Development
USDA IFx-EqM Field Study Planned for Product Commercialization
Big Pharma Discussions

2015

Scheduled to File IND for IFx-hu1.0 Clinical Trial